Detection of Gastric Cancer and Premalignant Lesions by Novel Marker Glycoprotein 87 Using Monoclonal Antibody Adnab-9

Cancer Epidemiology Biomarkers and Prevention

Volumn 12, Issue 10, 2003, Pages 1095-1099

  Qiao, Shi Xing ^a   Yuan, Mei ^a   Liu, Yia Li ^a   Lin, Xing Shi ^a   Zhang, Xiao Ping ^a   Tobi, Martin ^b,c  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; GLYCOPROTEIN GP 87; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY ADNAB 9; UNCLASSIFIED DRUG;

ADENOMA; ANTIGEN DETECTION; ARTICLE; ASIA; ATROPHIC GASTRITIS; CANCER EPIDEMIOLOGY; CANCER SCREENING; CANCER STAGING; CHRONIC GASTRITIS; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; EVALUATION; FECES ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; PANETH CELL; PATHOLOGICAL ANATOMY; PRECANCER; PREVALENCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMACH JUICE; TISSUE SPECIFICITY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; GASTRIC JUICE; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0142150057     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Parkin, D. M., Pisani, P., and Ferlay, J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int. J. Cancer, 54: 594-606, 1993.
2. Hisamichi, S. Screening for gastric cancer. World J. Surg., 13: 31-37, 1989.
3. Ellis, D. J., Speirs, C., Kingston, R. D., Brookes, V. S., Leonard, J., and Dykes, P. W. Carcinoembryonic antigen levels in advanced gastric carcinoma. Cancer (Phila.), 42: 623-625, 1978.
4. Sikoroska, H., Shuster, J., and Gold, P. Clinical application of carcinoembryonic antigen. Cancer Detect. Prev., 12: 321-355, 1988.
5. Ritts, R., Del Villano, B., Go, V. L., Herberman, R. B., Klug, T. L., and Zurawski, V. R., Jr. Initial clinical evaluation of an immunoradiometric assay for CA19-9 using the NCI serum bank. Int. J. Cancer, 33: 339-345, 1984.
6. Albedi, F. M., Lorenzetti, E., Contini, M., and Nardi, F. Immature Paneth cells in intestinal metaplasia of gastric mucosa. Appl. Pathol., 2: 43-48, 1984.
7. Murata, K., Egami, H., Kiyohara, H., Oshima, S., Kurizaki, T., and Ogawa, M. Expression of group-II phospholipase A2 in malignant and non-malignant human gastric mucosa. Br. J. Cancer, 68: 103-111, 1993.
8. Tobi, M., Darmon, F., Phillips, T., Heller, T., Rozen, P., Nochomovitz, L. E., and Steinberg, W. M. Increased expression of a putative adenoma-associated antigen in pre-colonoscopic effluent of patients with colorectal cancer. Cancer Lett., 51: 21-25, 1990.
9. Tobi, M., Maliakkal, B. J., Alousi, M. A., Voruganti, V., Shafiuddin, M., An, T., Fligiel, S. E. M., Yang, S., Gesell, M. S., Hatfield, J., Kaila, V., Goo, R., and Luk, G. D. Cellular distribution of a colonic adenoma-associated antigen as defined by monoclonal antibody Adnab-9. Scand. J. Gastroenterol., 27: 737-742, 1992.
10. Tobi, M., Elitsur, Y., Moyer, M. P., Halline, A., Deutsch, M., Nochomovitz, L., and Luk, G. D. Mucosal origin and shedding of an early colonic tumor marker defined by Adnab-9 monoclonal antibody. Scand. J. Gastroenterol., 28: 1025-1034, 1993.
11. Tobi, M., Kaila, V., Gallinger, S., Fligiel, S., Hatfield, J., Sakr, W., Luk, G., and Odze, R. Monoclonal antibody Adnab-9 defines a preneoplastic marker in epithelium at risk for adenocarcinoma of the small intestine. Hum. Pathol., 30: 467-473, 1999.
12. Yuan, M., Xhang, X., Liu, Y., and Tobi, M. Sensitivity of fecal Adnab-9 testing for colorectal neoplasia. Gastroenterology, 110: A619, 1996.
13. Yuan, M., Liu, Y., Fei, L., Zhang, X., Zhang, X., Li, L., and Li, H. Detection of cancer-associated antigen in feces using monoclonal antibodies in the diagnosis of colon carcinoma. Chin. J. Cancer Res., 3: 63-67, 1991.
14. Tobi, M., Maliakkal, B. J., Zitron, I., Alousi, M., Goo, B. G., Nochomovitz, L. E., and Luk, G. D. Colonic effluent adenoma-associated antigen correlated with colorectal cancer is a membrane-bound glycoprotein. Cancer Lett., 67: 61-69, 1992.
15. Hsu, S. M., Raine, L., and Fanger, V. Use of avidin-biotin-peroxidase complex [ABC] in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody [PA] procedures. J. Histochem., 21: 577-580, 1981.
16. In: D. Ingram and R. Bloch (eds.), Mathematical Models in Medicine, Part 1. New York: John Wiley & Sons, 1984.
17. Guadagni, F., Roselli, M., Amato, T., Cosimelli, M., Perri, P., Casale, V., Carlini, M., Santoro, E., Cavaliere, R., and Greiner, J. W. CA72-4 measurement of tumor-associated glycoprotein 72 (TAG-72) as a serum marker in the management of gastric carcinoma. Cancer Res., 52: 1222-1227, 1992.
18. Yuan, M., Zhang, X. P., and Tobi, M. GP87, a gastrointestinal pre-malignant lesion marker. Zhong. Hua. Zhong. Liu. Za. Zhi., 17: 136, 1995.
19. Suerbaum, S., and Michetti, P. Medical progress: Helicobacter pylori infection. N. Engl. J. Med., 347: 1175-1186, 2002.
20. Parsonnet, J., Harris, R. A., Hack, H. M., and Owens, D. K. Modeling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials. Lancet, 348: 150-154, 1996.
21. Yoshihara, M., Sumii, K., Haruma, K., Kiyohira, K., Hattori, N., Kitadai, Y., Komoto, K., Tanaka, S., and Kajiyama, G. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. Am. J. Gastroenterol., 93: 1090-1096, 1998.
22. Kodoi, A., Yoshihara, M., Sumii, K., Haruma, K., and Kajiyama, G. Serum pepsinogen in screening for gastric cancer. J. Gastroenterol., 30: 452-460, 1995.
23. Miki, K., Morita, M., Sasajima, S., Hoshina, R., Kanda, E., and Urita, Y. Usefulness of gastric cancer screening using the serum pepsinogen test method. Am. J. Gastroenterol., 98: 735-739, 2003.
24. Ley, C., Mohar, A., Guarner, J., Herrera-Goepfert, R., Figueroa, L. S., Halperin, D., and Parsonnet, J. Screening markers for atrophic gastritis in Chiapas, Mexico. Cancer Epidemiol. Biomark. Prev., 10: 107-112, 2001.
25. Naylor, P. H., Renaud-Maher, C., Shezad, S., Alloju, M., and Tobi, M. Hemoccult™ cards for screening with a monoclonal antibody to a premalignant colon cancer marker (Adnab-9). Proc. Am. Assoc. Cancer Res., 40: 55, 1999.
26. Srivastava, S., Verma, M., and Henson, D. E. Biomarkers for early detection of colon cancer. Clin. Cancer Res., 7: 1118-1126, 2001.
27. Tobi, M., O'Kieffe, D., Trujillo, N., Nochomovitz, L. E., and Steinberg, W. M. Detection of carcinoembryonic antigen in colonic effluent by specific anti-CEA monoclonal antibodies. Cancer Lett., 67: 47-54, 1992.
28. Tobi, M., Prabhu, S., Gage, R., Orr, T., and Lawson, M. J. Colorectal cancer risk: the impact of evidence of a field effect of carcinogenesis on blinded diagnosis using an anti-adenoma antibody test performed on colonoscopic effluent. Dig. Dis. Sci., 47: 317-321, 2002.
29. Yuan, M., Fei, L. H., Li, L., and Zhang, X-P. Analysis the tumor-associated markers of gastric cancer and application in clinical diagnosis. Zhong. Hua. Zhong. Liu. Za. Zhi., 73: 457, 1993.
30. Caldas, C., Hahn, S. A., Hruban, R. H., Redston, M. S., Yeo, C. J., and Kern, S. E. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic hyperplasia. Cancer Res., 54: 3568-3573, 1994.